Trial record 1 of 1 for:
STEMNESS-CRC
A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03522649 |
|
Recruitment Status : Unknown
Verified May 2019 by 1Globe Biomedical Co., Ltd. ( 1Globe Health Institute LLC ).
Recruitment status was: Recruiting
First Posted : May 11, 2018
Last Update Posted : June 18, 2019
|
Sponsor:
1Globe Health Institute LLC
Information provided by (Responsible Party):
1Globe Biomedical Co., Ltd. ( 1Globe Health Institute LLC )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | November 2021 |
| Estimated Study Completion Date : | November 2021 |